GENE ONLINE|News &
Opinion
Blog

2022-06-06|

Pharmactive Enters Strategic Partnership with Nutraconnect for APAC

by GeneOnline
Share To

Pharmactive targets Asia Pacific Market with new collaboration

MADRID, June 7, 2022 /PRNewswire/ — Pharmactive Biotech Products, S.L.U., announces a new strategic partnership with Singapore-based Nutraconnect Pte, Ltd. to bring innovative, scientifically backed nutraceutical ingredients to the Asia-Pacific marketplace (not including Australia and New Zealand).

Pharmactive Enters Strategic Partnership with Nutraconnect for APAC: Alberto Espinel – Alberto Espinel, Ph.D., head of R&D of Pharmactive; Jean Marie Raymond – CEO & Founder of Pharmactive; Rohit Noronha – Chief Growth Officer of Nutraconnect

The partnership will combine the strengths of both companies into a greater whole. Pharmactive will provide its well-supported, clean-label botanical extract ingredients, while Nutraconnect will function as a growth engine for the region, connecting Pharmactive with local and regional nutraceutical players seeking high-quality, pure ingredients. Nutraconnect Pte., Ltd. is a start-up led by Rohit Noronha, co-founder and Chief Growth Officer, and Nikhil Prabhakar Sawant, co-founder and CEO. Both are highly experienced leaders in the nutraceutical industry.

“We are very fortunate to partner with Nutraconnect, as their team possesses a great deal of market and customer information and strategic insight, allowing for quick responses to potential customers in their local time-zone,” confides Jean-Marie Raymond, CEO and Founder of Pharmactive. “Asia is a tremendous growth-hub for Pharmactive. We already have had successes in Korea, Japan, Vietnam, and Malaysia with Affron® pure saffron extract and Aged Black Garlic [ABG+®]. Many Asian industry players, formulators, and brand owners approach us about new compounding formats or innovative product concepts to cross the nutraceutical/functional food and beverage divide. Asia is clearly the frontrunner in terms of new ingredient concepts.”

“When it comes to nutraceuticals, Asia-Pacific is a fast-moving region, with multiple players constantly on the lookout for the latest ingredients,” adds Sawant. “They expect great service and rapid response, even with difficult custom-made formulations,
questions about the regulatory framework in certain countries, etc., and this is exactly where our core strength lies. We look forward to helping Pharmactive meet challenges and grow its business in the APAC market.”

About Pharmactive

Pharmactive Biotech Products, S.L.U., is a Madrid-based pioneering biotechnology company that develops and manufactures differentiated natural ingredients supported by science, such as pure saffron extract and aged black garlic. The company’s mission is to make a daily positive and significant impact on people’s health and well-being through premium botanical ingredients backed by scientific studies and approved by ethics committees. Pharmactive grows, cultivates, and produces farm-to-fork botanical ingredients with a minimal ecological footprint.

About Nutraconnect

Founded in 2022, Nutraconnect Pte., Ltd., is a nutraceutical business growth acceleration service headquartered in Singapore. The company provides end-to-end solutions for global nutraceutical ingredient manufacturers that are looking to establish a foundation for sustainable growth in the fragmented, but booming APAC market. Visit www.nutraconnect.com.sg to learn more about the company and its services.

For more information, contact

Company Contact:

 

Press Contact:

Pharmactive Biotech Products, S.L.U.

NutriPR

Mariana Ortega

Marketing Associate

Tel: +34 625 926 940

Email: mortega@pharmactive.eu

Liat Simha

Tel: +972-9-9742893

E-mail: liat@nutripr.com

 

Twitter: @Pharmactive_SP

Twitter: @NutriPR_

Web: www.pharmactive.eu

Web: www.nutripr.com

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Lunit AI Solutions to Power Samsung’s X-ray Devices for Advanced Chest Screening
2024-01-16
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
2023-12-24
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
2023-12-17
LATEST
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top